About the Infographic
- Early clinical highlights, including preliminary results for the PARP1-selective AZD5305 and the ATRi RP-3500.
- A review of emerging preclinical and clinical WEE1i data, including a look at developers investigating WEE1.
- A brief look at the future of synthetic lethality.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements